Company: SMNR
Filing Date: 2025-07-02
Form Type: S-4/A
Source: 0001193125-25-154936
Chunk: 1082

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-02
Form: S-4/A
Chunk 1082
---
ness Opinion of CB Capital Partners, Inc. in relation to Valuation of Semnur Pharmaceuticals, Inc. by Denali Capital Acquisition Corp., dated August 30, 2024 (included as Annex H to the proxy statement/prospectus contained in this registration statement).99.8‡Consent of CB Capital Partners, Inc.101.INSInline XBRL Instance Document.101.SCHInline XBRL Taxonomy Extension Schema Document.II-4
| Exhibit 
 Number  |     | Description                                                                               |
| 101.CAL |     | Inline XBRL Taxonomy Extension Calculation Linkbase Document.                             |
| 101.DEF |     | Inline XBRL Taxonomy Extension Definition Linkbase Document.                              |
| 101.LAB |     | Inline XBRL Taxonomy Extension Labels Linkbase Document.                                  |
| 101.PRE |     | Inline XBRL Taxonomy Extension Presentation Linkbase Document.                            |
| 104     |     | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
| 107‡    |     | Filing Fee Table.                                                                         |

| ‡ | Previously filed. |

| + | To be filed by amendment. |

| * | Indicates management contract or compensatory plan or arrangement. |

| 

# | Certain of the exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601. The Registrant agrees to furnish a copy of all omitted exhibits and schedules to the SEC upon its request. |
| ^ | Certain identified information has been omitted pursuant to Item 601(b)(10) of Regulation S-K because such information is both (i) not material and (ii) information that the Registrant treats as private or confidential. The Registrant hereby undertakes to furnish supplemental copies of the unredacted exhibit upon request by the SEC. |

II-5

Item 22. Undertakings. The undersigned registrant hereby undertakes:

| (1) | To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: |

| (i) | To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |

| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth